Effect of ayurvedic drug intervention in hypertensio

Phase 2

• Conditions: Health Condition 1: I10- Essential (primary) hypertension

• Registration Number: CTRI/2021/12/038883
• Lead Sponsor: KAHERS SHRI BMK AYURVEDA MAHAVIDYALAYA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Criteria for the selection of the patients will be based on the criteria suggested by Joint National Committee 8

In patients aged less than 60 years with Systolic Blood Pressure greater than 140 mm Hg and Diastolic Blood Pressure greater than 90 mm Hg

In patients aged more than 60 years with Systolic Blood pressure greater than 150 mm Hg and Diastolic Blood Pressure greater than 90 mm Hg

Stages of Grade 1 Hypertension SBP 140 to 159 DBP 90 to 99mm Hg

Patients between 20 to 70 years age of either sex

Exclusion Criteria

Ischemic heart disease Coronary heart disease Coronary artery disease and coarctation of aorta

Renal failure Endocrine diseases,

Hypertension with cerebral complications like hypertensive encephalopathy cerebral haemorrhage convulsive seizure

Malignant hypertension

Pregnant and Lactating female patients

Patient on treatment for hypertension since 1 month

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
SUBJECTIVE PARAMETERS <br/ ><br>Primary Assessment Criteria <br/ ><br>Systolic blood pressure <br/ ><br>Diastolic blood pressure <br/ ><br>Secondary Assessment Criteria <br/ ><br>Mean arterial pressure <br/ ><br>Depression Anxiety Stress Scale long form DASS-42 <br/ ><br> Short Form 36 Quality of life <br/ ><br> 2 weeks sleep diary <br/ ><br> Pittsburgh Sleep Quality Index (PSQI)Timepoint: 0th day 15th day 30th day 45th day 60th day

Secondary Outcome Measures

Name	Time	Method
ILTimepoint: NI